| 2024 | 2023 | |||
|---|---|---|---|---|
| Gross margin | -8,2 k € | +79.3% | -39,5 k € | |
| EBITDA | -8,6 k € | +78.5% | -39,9 k € | |
| Operating profit | -188,6 k € | +53.4% | -404,4 k € | |
| Profit/loss | -188,7 k € | +53.3% | -404,4 k € | |
| Equity | 1,4 M € | +70.8% | 844,6 k € | |
| Total assets | 1,8 M € | +19.0% | 1,5 M € | |
| Cash | 633,5 k € | +191.2% | 217,5 k € | |
| Debts | 360,3 k € | -46.3% | 670,5 k € | |
Public limited company · Waterloo · incorporated on 16/12/2022
Public limited company loss-making in the latest fiscal year. Cash position rising (+191.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
OLFADOG BIOTECH is a Public limited company incorporated in 2022. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Waterloo.